GGrantIndex
Sort

11,323 grants matching glioblastoma

Chemosensitization of Glioblastoma by Propentofylline

$399,998
Nhan L Tran · Oleolive, Inc. · R41 · FY2022 · CA

Phase 2 Study of TH-302 for the Treatment of Glioblastoma

$399,998
Andrew Jacob Brenner · University Of Texas Hlth Science Center · R01 · FY2017 · FD

Targeting N-linked Glycosylation to Enhance Radiation Therapy

$399,961
Joseph N Contessa · Yale University · R01 · FY2017 · CA

Role of MELK in glioblastomas

$399,939
Alexey V Terskikh · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2012 · NS

Role of MELK in glioblastomas

$399,939
Alexey V Terskikh · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2011 · NS

Development of the New Synthetic Triterpenoid CDDO-2P-IM (TTX01) for Glioblastoma

$399,908
Michael B Sporn · Triterpenoid Therapeutics, Inc. · R43 · FY2020 · CA

New models for interrogating the impact of sex chromosomes and sex hormones on glioblastoma

$399,829
Joseph Edward Ippolito · Washington University · R21 · FY2025 · CA

Sub-component for Institution # 16-01848 Novel moleculary targeted therapy of GBM

$399,814
Waldemar Debinski · Wake Forest University Health Sciences · P01 · FY2021 · CA

Understanding How Thiolates Promote Dioxygen Chemistry

$399,795
Julia A Kovacs · University Of Washington · R01 · FY2021 · GM

Understanding How Thiolates Promote Dioxygen Chemistry

$399,795
Julia A Kovacs · University Of Washington · R01 · FY2019 · GM

Understanding How Thiolates Promote Dioxygen Chemistry

$399,795
Julia A Kovacs · University Of Washington · R01 · FY2020 · GM

Preclinical Studies to Develop an Eya2 Tyr Phosphatase Inhibitor as a Novel Medulloblastoma Therapeutic

$399,709
Heide L Ford · Sieyax, Inc · R41 · FY2024 · CA

Engineered Glioblastoma-specific T cells using Immunostimulatory Photothermal Nanoparticles

$399,669
Elizabeth E Sweeney · Immunoblue, Llc · R41 · FY2024 · CA

Controlled Release of Macromolecules

$399,667
Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2012 · EB

Integrative Cancer Genomics: Drivers, Pathways and Drugs

$399,632
Dana Pe'er · Columbia Univ New York Morningside · R01 · FY2012 · CA

MR Signal Amplification for Receptor Imaging

$399,623
Alexei A Bogdanov · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · EB

Chromatin Modifications in GBM-Propagating Cells

$399,522
John J Laterra · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2021 · NS

Pten and P13K regulation of growth and neoplasia in the brain

$399,518
Suzanne J Baker · St. Jude Children'S Research Hospital · R01 · FY2008 · CA

Intranasal Stem-Cell Based Therapy for Glioblastoma

$399,501
Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2018 · NS

Intravital Microscopy Core

$399,454
Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2016 · CA

Phase 2 Study of TH-302 for the Treatment of Glioblastoma

$399,446
Andrew Jacob Brenner · University Of Texas Hlth Science Center · R01 · FY2016 · FD

Transfer of microRNA regulators from glioblastoma to brain microenvironment

$399,348
Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2014 · CA

Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma

$399,338
Daniela Annenelie Bota · University Of California-Irvine · R01 · FY2024 · NS

Development of Immunostimulatory Virotherapy Without Neurotoxicity for the Treatment of Brain Malignancies

$399,335
Matthew Stremlau · Implicyte, Inc. · R43 · FY2021 · CA

Off-the-shelf engineered NK cells to treat glioblastoma

$399,314
Joe Trebley · Monon Bioventures, Llc · R43 · FY2022 · CA